Cellectis (CLLS) Gross Margin (2016 - 2023)
Historic Gross Margin for Cellectis (CLLS) over the last 9 years, with Q3 2023 value amounting to 16.77%.
- Cellectis' Gross Margin rose 929400.0% to 16.77% in Q3 2023 from the same period last year, while for Sep 2023 it was 92.36%, marking a year-over-year increase of 774700.0%. This contributed to the annual value of 93.11% for FY2022, which is 1009900.0% up from last year.
- Latest data reveals that Cellectis reported Gross Margin of 16.77% as of Q3 2023, which was up 929400.0% from 69.1% recorded in Q2 2023.
- In the past 5 years, Cellectis' Gross Margin ranged from a high of 95.69% in Q4 2022 and a low of 140.29% during Q1 2023
- Over the past 5 years, Cellectis' median Gross Margin value was 0.68% (recorded in 2021), while the average stood at 6.46%.
- As far as peak fluctuations go, Cellectis' Gross Margin soared by 963700bps in 2022, and later plummeted by -2171600bps in 2023.
- Cellectis' Gross Margin (Quarter) stood at 27.79% in 2019, then tumbled by -32bps to 36.6% in 2020, then skyrocketed by 98bps to 0.68% in 2021, then surged by 14173bps to 95.69% in 2022, then plummeted by -118bps to 16.77% in 2023.
- Its last three reported values are 16.77% in Q3 2023, 69.1% for Q2 2023, and 140.29% during Q1 2023.